MedPath

ROSWELL PARK CANCER INSTITUTE

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Exercise in Improving Health and Quality of Life in Breast Cancer Survivors

Not Applicable
Completed
Conditions
Invasive Breast Carcinoma
Interventions
Other: Best Practice
Behavioral: Exercise Intervention (home walking program and resistance training)
Behavioral: Exercise Intervention (home-based Zumba program and resistance training)
Behavioral: Exercise Intervention (HIIT program and resistance training)
Device: Monitoring Device
Other: Informational Intervention
Other: Quality-of-Life Assessment
Other: Laboratory Biomarker Analysis
Other: Questionnaire Administration
First Posted Date
2018-09-20
Last Posted Date
2023-09-01
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
83
Registration Number
NCT03679559
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Talking Pictures Social Media Intervention in Reducing Depressive Symptoms and Improving Spiritual Well-Being and Quality of Life in Adolescent and Young Adult Cancer Patients

Not Applicable
Completed
Conditions
Malignant Neoplasm
Interventions
Other: Internet-Based Intervention
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
First Posted Date
2018-09-20
Last Posted Date
2022-07-25
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
30
Registration Number
NCT03679585
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery

Phase 1
Active, not recruiting
Conditions
Non-Small Cell Lung Carcinoma
Pleural Disorder
Malignant Mesothelioma
Interventions
Device: Light Dosimetry for Intranoperative Therapy
Procedure: Photodynamic Therapy
First Posted Date
2018-09-19
Last Posted Date
2025-05-11
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
9
Registration Number
NCT03678350
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy Volunteers

Not Applicable
Terminated
Conditions
Healthy Subject
Breast Carcinoma
Malignant Soft Tissue Neoplasm
Sarcoma
Skin Carcinoma
Interventions
Procedure: Photoacoustic Imaging
First Posted Date
2018-08-15
Last Posted Date
2023-03-31
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
7
Registration Number
NCT03630601
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Chemokine Modulation Therapy and Pembrolizumab in Treating Participants With Metastatic Triple-Negative Breast Cancer

Early Phase 1
Completed
Conditions
Triple -Negative Breast Cancer
Estrogen Receptor Negative
Anatomic Stage IV Breast Cancer AJCC
HER2/Neu Negative
Progesterone Receptor Negative
Interventions
Procedure: Biopsy
Procedure: Chemokine Modulation Therapy
Biological: Recombinant Interferon Alfa-2b
Biological: Pembrolizumab
First Posted Date
2018-07-26
Last Posted Date
2023-07-18
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
8
Registration Number
NCT03599453
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy

Not Applicable
Completed
Conditions
Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8
Interventions
First Posted Date
2018-07-02
Last Posted Date
2021-12-09
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
62
Registration Number
NCT03574792
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Problem Solving Skills Training in Adult Cancer Survivors: Bright IDEAS-AC

Not Applicable
Completed
Conditions
Colo-rectal Cancer
Interventions
Behavioral: Problem solving Skills Training
First Posted Date
2018-06-26
Last Posted Date
2022-09-28
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
50
Registration Number
NCT03567850
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Abatacept, Ixazomib Citrate, and Dexamethasone in Treating Patients With Multiple Myeloma Resistant to Chemotherapy

Phase 2
Terminated
Conditions
Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma
Interventions
First Posted Date
2018-03-07
Last Posted Date
2025-03-04
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
15
Registration Number
NCT03457142
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

πŸ‡ΊπŸ‡Έ

St. Francis Hospital, East Hills, New York, United States

πŸ‡ΊπŸ‡Έ

Good Samaritan Hospital, West Islip, New York, United States

Antioxidant Supplements, Genetics and Chemotherapy Outcomes

Completed
Conditions
Node Positive Breast Cancer
Node Negative Breast Cancer
First Posted Date
2018-01-29
Last Posted Date
2022-08-08
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
1771
Registration Number
NCT03413761

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

Phase 2
Completed
Conditions
Metastatic Carcinoma in the Liver
Recurrent Colorectal Carcinoma
Stage IV Colorectal Cancer AJCC v7
Stage IVA Colorectal Cancer AJCC v7
Stage IVB Colorectal Cancer AJCC v7
Interventions
Other: Laboratory Biomarker Analysis
Biological: Recombinant Interferon Alfa-2b
First Posted Date
2018-01-18
Last Posted Date
2022-03-02
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
19
Registration Number
NCT03403634
Locations
πŸ‡ΊπŸ‡Έ

Roswell Park Cancer Institute, Buffalo, New York, United States

Β© Copyright 2025. All Rights Reserved by MedPath